GNOM

Global X Genomics & Biotechnology ETF
*Unless otherwise stated, data provided by FactSet.

GNOM Fund Description

GNOM tracks an index of global biotech equities, selected and weighted by market cap.

GNOM Factset Analytics Insight

GNOM is Global X’s take on biotech, with more of an emphasis on genomics specifically. The fund fleshes out its description of this sector by including companies that derive more than 50% of their revenues from the following five business activities: (i) gene editing, (ii) genomic sequencing, (iii) development and testing of genetic medicine/therapies, (iv) computational genomics and genetic diagnostics, and/or (v) biotechnology. The fund uses a proprietary natural language processing algorithm to identify and rank eligible firms based on public documents, such as filings and disclosures. Holdings may span the market-cap spectrum and come from across the globe, including some emerging markets. The market-cap-weighted index is reconstituted and rebalanced semi-annually.

GNOM MSCI ESG Analytics Insight

Global X Genomics & Biotechnology ETF has an MSCI ESG Fund Rating of BB based on a score of 3.71 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Global X Genomics & Biotechnology ETF ranks in the 10th percentile within its peer group and in the 20th percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

PERFORMANCE [as of 06/10/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
GNOM 6.67% -1.36% -4.49% 34.37% -- -- --
GNOM (NAV) 14.32% 1.94% -2.20% 29.17% -- -- --
Solactive Genomics Index -- -- -- -- -- -- --
N/A -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

GNOM Summary Data

Global X
04/05/19
Open-Ended Fund
0.50%
$212.80M
$2.07M
0.25%
BBH

GNOM Portfolio Data

$11.81B
-23.56
5.68
--
06/29/21
40

GNOM Index Data

Solactive Genomics Index
Market Cap
Market Cap
N/A

GNOM Portfolio Management

0.50%
--
--
--

GNOM Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

GNOM Fund Structure

Open-Ended Fund
No
No
-- / --
N/A
N/A
Low
Daily

GNOM Factset Analytics Block Liquidity

As of 06/11/21
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of GNOM. GNOM is rated a 5 out of 5.

GNOM Tradability

95,237
$2.07M
81,665
$1.77M
0.25%
$0.05
0.20%
4.68% / -2.12%
None
94.00%
50,000
1.63
--
0.09%
693
$23.07
5

GNOM Sector/Industry Breakdown


GNOM
Segment Benchmark
69.23%
94.97%
27.20%
0.12%
3.58%
0.37%

GNOM Top 10 Holdings[View All]

4.80%
CareDx, Inc. 4.63%
3.93%
Natera, Inc. 3.75%
43.42%

GNOM Countries


GNOM
Segment Benchmark
94.98%
75.42%
2.80%
5.73%
1.35%
1.07%
0.87%
0.48%
--
0.02%
--
0.63%
--
0.87%
--
0.04%
--
0.04%
--
0.25%

GNOM Regions


GNOM
Segment Benchmark
94.98%
75.79%
4.15%
11.36%
0.87%
12.81%
--
0.04%

GNOM Economic Development


GNOM
Segment Benchmark
100.00%
99.60%
--
0.40%

GNOM Performance Statistics

--
--
--
--
0.00%
N/A

GNOM MSCI ESG Ratings

3.71 / 10
20.34
10.39
--
12.36%
26.49

GNOM Benchmark Comparison Holdings

40
421
30
11.52%

GNOM Benchmark Comparison Summary


GNOM
Segment Benchmark
40
421
$11.81B
$26.51B
-23.56
-47.19
5.68
6.28
0.13%
0.33%
Medium
Medium

GNOM Benchmark Comparison Market Cap Size


GNOM
Segment Benchmark
19.54%
54.39%
60.21%
25.87%
18.80%
15.74%
1.44%
4.01%